LLY vs UPBD · P/E 39, rev $22.97B vs P/E 12, rev $2.38B
Eli Lilly and Company (LLY) versus Upbound Group Inc. (UPBD) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Upbound Group Inc. (UPBD) is a software - application company listed on NASDAQ.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported UPBD revenue for 2026-06-30 was $2.38B. Net income was $57.4M. Revenue was up 95.4% from 2026-03-31 to 2026-06-30. UPBD currently screens at market cap $1.02B and trailing P/E 12.1.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. UPBD currently screens at market cap $1.02B and trailing P/E 12.1.
Not investment advice. Open the LLY and UPBD stock pages for the full models.
Not investment advice.